AZ HB2617

Prohibits health insurers from imposing cost sharing requirements (copays, deductibles) for diagnostic prostate cancer screenings for high-risk patients, effective January 1, 2027.

Defines "high-risk" as men at least 40 years of age who are of African ancestry, carry the BRCA1 or BRCA2 gene, have a family history of prostate cancer, or are military veterans exposed to Agent Orange.

Family history includes having a first-degree relative who was diagnosed with prostate cancer before age 60, died of prostate cancer, developed cancer associated with increased prostate cancer risk, or was diagnosed with a related genetic mutation.

Applies to hospital service corporations, medical service corporations, health care services organizations, and disability insurers issuing individual or group policies.

Cost sharing prohibition does not apply to out-of-network screenings.